Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis.

Abstract excerpt

In a recent investigation we found that hospitalized patients with cystic fibrosis who received 0.5 cc of 0.5% albuterol nebulizer solution TID significantly increased their pulmonary function across the day, but fell back to baseline overnight. To determine whether this fall could be prevented by the long-acting beta-2 agonist salmeterol at both standard (2 puffs: 42 mcg BID) and high (4 puffs, 84 mcg BID)...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Administration, Inhalation
• Share to Adrenergic beta-Agonists